SVETLANA BROTHERS: Open Payments
NPI 1437485893 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 44 payments from 8 companies in 2025. Trend: 2023 $224 · 2024 $655 · 2025 $1,318
Food & beverage: $1,241Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $341 |
| Janssen Biotech, Inc. | 9 | $308 |
| Gilead Sciences, Inc. | 5 | $245 |
| Madrigal Pharmaceuticals | 2 | $163 |
| Regeneron Healthcare Solutions, Inc. | 1 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 1 | $31 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, DUPIXENT, Livdelzi, LINZESS, XIFAXAN, VOQUEZNA.
Industry payments across NM — which companies pay providers there.
